World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
75
Citations
23254
World Ranking
1187
National Ranking
615

Stephan W. Morris publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Stephan W. Morris sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 171 publications — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Stephan W. Morris D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Stephan W. Morris sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 75 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Stephan W. Morris is affiliated with St. Jude Children's Research Hospital in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on subfields such as Immunology, Pathology and Forensic Medicine, Cancer Research, Hematology, and Oncology.

Their work covers a range of topics including Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Protein Degradation and Inhibitors, Cancer Genomics and Diagnostics, T-cell and Retrovirus Studies, Cutaneous lymphoproliferative disorders research, and Microtubule and mitosis dynamics.

Stephan W. Morris has contributed to several recent publications, such as:

  • Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice, 2022, Journal of Clinical Oncology
  • Covalent Menin Inhibitor Bmf-219 in Patients with Relapsed or Refractory (R/R) Acute Leukemia (AL): Preliminary Phase 1 Data from the Covalent-101 Study, 2023, Blood
  • Relieving DYRK1A repression of MKL1 confers an adult-like phenotype to human infantile megakaryocytes, 2022, Journal of Clinical Investigation
  • Complete remission of NUP98 fusion-positive acute myeloid leukemia with the covalent menin inhibitor BMF-219, icovamenib, 2024, Haematologica
  • Covalent-103: A phase 1, open-label, dose-escalation and expansion study of BMF-500, an oral covalent FLT3 inhibitor, in adults with acute leukemia (AL)., 2024, Journal of Clinical Oncology

Frequently publishing in the Journal of Clinical Oncology, Blood, Cancer Research, Journal of Clinical Investigation, and Haematologica, their body of work demonstrates engagement across multiple high-impact oncology and hematology journals.

Stephan W. Morris has collaborated regularly with coauthors including Thomas W. Butler, Farhad Ravandi, Gary J. Schiller, Uzma Ahmed, and Alexandru Cacovean, reflecting a network of research partnerships primarily in cancer and hematology studies.

Best Publications

  • Fusion of a Kinase Gene, ALK, to a Nucleolar Protein Gene, NPM, in Non-Hodgkin's Lymphoma

    SW Morris;MN Kirstein;MB Valentine;KG Dittmer;KG Dittmer

  • Activating mutations in ALK provide a therapeutic target in neuroblastoma

    Rani E. George;Takaomi Sanda;Megan C. Hanna;Stefan Fröhling

  • Detection of Anaplastic Lymphoma Kinase (ALK) and Nucleolar Protein Nucleophosmin (NPM)-ALK Proteins in Normal and Neoplastic Cells With the Monoclonal Antibody ALK1

    Karen Pulford;Laurence Lamant;Laurence Lamant;Laurence Lamant;Stephan W. Morris;Stephan W. Morris;Stephan W. Morris;Lisa H. Butler;Lisa H. Butler;Lisa H. Butler

  • Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma

    Randy D. Gascoyne;Patricia Aoun;Patricia Aoun;Patricia Aoun;Daniel Wu;Daniel Wu;Daniel Wu;Mukesh Chhanabhai;Mukesh Chhanabhai;Mukesh Chhanabhai

  • ALK , the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

    Stephan W Morris;Clayton Naeve;Prasad Mathew;Payton L James

  • ALK-Positive Lymphoma: A Single Disease With a Broad Spectrum of Morphology

    Daniel Benharroch;Zarouhie Meguerian-Bedoyan;Laurence Lamant;Chauki Amin

  • Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study.

    James Cook;Louis Dehner;Margaret Collins;Zhigui Ma

  • Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes.

    Dirk M. Anderson;Satoru Kumaki;Minoo Ahdieh;Jeanette Bertles

  • Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis

    D Bischof;K Pulford;D Y Mason;S W Morris

  • Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).

    Quangeng Zhang;Reiner Siebert;Minhong Yan;Bernd Hinzmann

  • Nucleophosmin–anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway

    Ren Yuan Bai;Tao Ouyang;Tao Ouyang;Cornelius Miething;Cornelius Miething;Stephan W. Morris;Stephan W. Morris

  • A New Subtype of Large B-Cell Lymphoma Expressing the ALK Kinase and Lacking the 2; 5 Translocation

    Georges Delsol;Laurence Lamant;Bernard Mariamé;Karen Pulford

  • The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors.

    Hiromitsu Hara;Chitose Ishihara;Arata Takeuchi;Takayuki Imanishi

  • Nucleophosmin-Anaplastic Lymphoma Kinase of Large-Cell Anaplastic Lymphoma Is a Constitutively Active Tyrosine Kinase That Utilizes Phospholipase C-γ To Mediate Its Mitogenicity

    Ren Yuan Bai;Peter Dieter;Christian Peschel;Stephan W. Morris

  • The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1

    Yoneda-Kato N;Look At;Kirstein Mn;Valentine Mb

  • Multilevel Dysregulation of STAT3 Activation in Anaplastic Lymphoma Kinase-Positive T/Null-Cell Lymphoma

    Qian Zhang;Puthryaveett N. Raghunath;Liquan Xue;Miroslaw Majewski

  • Translocations involving anaplastic lymphoma kinase (ALK)

    Justus Duyster;Ren Yuan Bai;Stephan W. Morris

  • Retrovirus-Mediated Gene Transfer of NPM-ALK Causes Lymphoid Malignancy in Mice

    Martin U. Kuefer;A. Thomas Look;Karen Pulford;Frederick G. Behm

  • Fusion of the ALK Gene to the Clathrin Heavy Chain Gene, CLTC, in Inflammatory Myofibroblastic Tumor

    Julia A. Bridge;Masahiko Kanamori;Zhigui Ma;Diane Pickering

  • Anaplastic lymphoma kinase proteins in growth control and cancer.

    K. Pulford;S. W. Morris;Francesco Turturro

Frequent Co-Authors

Christian Peschel
Christian Peschel Technical University of Munich
A. Thomas Look
A. Thomas Look Harvard University
Karen Pulford
Karen Pulford University of Oxford
Marcus B. Valentine
Marcus B. Valentine St. Jude Children's Research Hospital
Demin Wang
Demin Wang Medical College of Wisconsin
Georges Delsol
Georges Delsol Federal University of Toulouse Midi-Pyrénées
David Y. Mason
David Y. Mason John Radcliffe Hospital
Debra J. Gilbert
Debra J. Gilbert National Institutes of Health
Neal G. Copeland
Neal G. Copeland The University of Texas MD Anderson Cancer Center
Nancy A. Jenkins
Nancy A. Jenkins The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in molecular biology opens doors to a wide range of interdisciplinary opportunities, especially in health sciences. Students often consider complementary paths such as pursuing online ABSN programs for non nurses to quickly transition into nursing without prior experience. This flexibility is essential for those seeking to integrate biological sciences with hands-on patient care.

For those looking to advance, understanding how to become nurse practitioner efficiently is important. Accelerated study options, such as the fastest RN to BSN program online, enable students to achieve credentials while balancing work and life.

Molecular biology graduates might also be interested in emerging interdisciplinary careers, including mental health care. Advanced clinical roles like DNPs offer the potential to specialize and earn competitive pay, with resources available to compare DNP psychiatric nurse practitioner salary by state. These pathways illustrate the diverse options and strong career outcomes available to those with a background in molecular biology and related sciences.

Best Scientists Citing Stephan W. Morris

Trending Scientists

Recently Published Articles